FDA Adverse Event Injury Summary report: N

TOTAL ASR FEM IMP SIZE 55

MDR report key: 2915178 · Received January 15, 2013

Report

Report Number
1818910-2013-00917
Event Type
Injury
Date Received
January 15, 2013
Date of Event
March 11, 2007
Report Date
January 3, 2013
Manufacturer
DEPUY INTERNATIONAL LTD. 8010379
Product Code
KXA
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. REF. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY.

Additional Manufacturer Narrative · 1

THE REPORTED EVENT HAS BEEN EVALUATED AND WILL BE MONITORED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 1

ASR REVISION; ASR RESURFACING SYSTEM - LEFT HIP; REASON FOR REVISION: UNKNOWN.

Description of Event or Problem · 1

UPDATE JUL 24, 2017: CLAIM LETTER RECEIVED. THERE IS NO NEW INFORMATION ADDED THAT CHANGES THE MDR DECISION. ADDED COMPLAINANT INFORMATION. THIS COMPLAINT WAS UPDATED ON: SEP 05, 2017.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
22304 TOTAL ASR FEM IMP SIZE 55 HIP FEMORAL HEAD KXA DEPUY INTERNATIONAL LTD. 8010379 1158123

Patients

Seq Age Sex Outcome Treatment
1 50 YR Required Intervention